Drug intelligence / Profile preview

O24 Pain Neutralizer

Development stage
Unknown
Lead developer
O24 Naturals
Modality
Small Molecules
Administration
Topical
01

Overview

O24 Pain Neutralizer is an over-the-counter topical analgesic product designed for the temporary relief of minor aches and pains associated with arthritis, backaches, muscle strains, and sprains. Marketed by O24 Naturals, LLC, the product is available in multiple formulations: one utilizing the homeopathic ingredient Arnica montana 2X HPUS, and others containing camphor as the primary active ingredient. The product is delivered through various formats, including sprays, roll-ons, and towelettes. It is characterized as a 100% natural blend of essential oils that functions by regulating temperature at the site of application to reduce inflammation and alleviate pain. While the camphor-based version follows standard OTC monographs, the homeopathic version has not been evaluated by the FDA for safety or efficacy.

Brand names
O24 Pain NeutralizerO-24 Pain NeutralizerO 24 Pain Neutralizer
Other names
O24O-24O 24
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on O24 Pain Neutralizer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on O24 Pain Neutralizer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call